ACC.26 advanced registration ends Feb. 12 – register now!

Richard J. Glassock, MD

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Genentech(MODEST), Apellis(MODEST), Mallinckrodt(MODEST), Ionis(MODEST), Achillion(MODEST), Retrophin(MODEST) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Reata(MODEST) SALARY: Wolters-Kluwer(SIGNIFICANT)

View Full Disclosure